pSivida Corp

Press Releases

All Releases
View Summary Abstract on pSivida's Treatment of Posterior Segment Uveitis Accepted for Presentation at the 2017 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
Mar 15, 2017
PDF 19.0 KB Add to Briefcase
View Summary pSivida to Present at the 2017 BIO CEO & Investor Conference
Feb 10, 2017
PDF 15.5 KB Add to Briefcase
View Summary pSivida Corp. Reports Fiscal 2017 Second Quarter and First Half Results
Feb 7, 2017
PDF 35.0 KB Add to Briefcase
View Summary pSivida Corp. Announces Second Quarter Fiscal Year 2017 Financial Results Release Date and Conference Call Information
Jan 25, 2017
PDF 18.4 KB Add to Briefcase
View Summary Seasoned Ophthalmology Executive Deb Jorn Joins pSivida to Focus on Corporate and Commercial Development
Nov 7, 2016
PDF 16.4 KB Add to Briefcase
View Summary pSivida Corp. Reports Fiscal 2017 First Quarter Results and Provides Update on Corporate Objectives & Milestone Timeline
Nov 7, 2016
PDF 32.7 KB Add to Briefcase
View Summary pSivida Corp. Announces First Quarter Fiscal Year 2017 Financial Results Release Date and Conference Call Information
Oct 31, 2016
PDF 17.9 KB Add to Briefcase
View Summary Phase 3 trial of Medidur™ in Posterior Segment Uveitis Meets Enrollment Target
Oct 4, 2016
PDF 19.1 KB Add to Briefcase
View Summary pSivida Corp. Strengthens Board of Directors With Leading Ophthalmologist
Sep 27, 2016
PDF 18.2 KB Add to Briefcase
View Summary pSivida to Present at the Ladenburg Thalmann Annual Healthcare Conference
Sep 22, 2016
PDF 14.0 KB Add to Briefcase
View Summary pSivida Reports Inducement Awards to New President and Chief Executive Officer
Sep 20, 2016
PDF 14.0 KB Add to Briefcase
View Summary pSivida Implements Leadership Change -- Nancy Lurker Named as President and CEO
Sep 15, 2016
PDF 18.7 KB Add to Briefcase
View Summary pSivida Corp. Provides Company Update and Reports Fourth Quarter and FY 2016 Results
Sep 12, 2016
PDF 37.8 KB Add to Briefcase
View Summary pSivida Corp. Announces Fourth Quarter and Fiscal Year 2016 Financial Results Release Date and Conference Call Information
Sep 1, 2016
PDF 14.1 KB Add to Briefcase
View Summary pSivida Announces 13 New Patents Issued or Allowed
Aug 29, 2016
PDF 17.4 KB Add to Briefcase
View Summary Topline Results from First Phase 3 Trial of pSivida's Medidur™ Presented at ASRS Annual Meeting
Aug 15, 2016
PDF 18.3 KB Add to Briefcase
View Summary Primary Endpoint Met in pSivida's Utilization Study of New Medidur™ Inserter with Smaller Diameter Needle
Aug 9, 2016
PDF 18.3 KB Add to Briefcase
View Summary pSivida Names Dario Paggiarino, M.D. as Chief Medical Officer
Aug 3, 2016
PDF 16.9 KB Add to Briefcase
View Summary pSivida Corp and Hospital for Special Surgery Innovation Center Announce Opening of IND for Sustained-Release Implant for Severe Knee Osteoarthritis
Aug 1, 2016
PDF 24.0 KB Add to Briefcase
View Summary pSivida's Medidur™ Maintains Same High Statistical Significance in Primary Endpoint through 12 Months in First Phase 3 Trial (p Less Than 0.00000001)
Jul 27, 2016
PDF 22.2 KB Add to Briefcase
Showing 1-20 of 270 Page: 1 2 3 4 5 ... 14  Next 20
Add to Briefcase = add release to Briefcase

Search Investor Relations

pSivida